Corona vaccine: The Kovacin vaccine may receive international approval at the WHO meeting today.

Agency, New Delhi

Published by: Kuldeep Singh |
Updated to Tuesday, 26 October 2021 03:10 AM IST

Summary

Kovacin, India’s first indigenous vaccine, can be approved internationally today. The decision could be taken at today’s World Health Organization (WHO) meeting.

Listen to the news

Kovacin, India’s first indigenous vaccine to prevent the corona epidemic, is being approved internationally today. The decision could be taken at today’s World Health Organization (WHO) meeting.

A decision on this will be taken at the World Health Organization meeting to be held today
WHO Chief Scientist Dr Soumya Swaminathan said last week that the decision to add covacin vaccine from India Biotech to the world-class emergency list would be taken at a meeting on October 26.

The WHO said Bharat Biotech had provided all the documents related to Kovacsin, the review of which was almost complete. At Tuesday’s meeting, the committee’s experts will not only express their views, but will also consider the vaccine’s effectiveness, safety and antibody level, based on which Kovacin can be added to the list. Emergency use.

Covaxin is not yet internationally approved, making Covaxin supplements not eligible for overseas travel. In most countries, only people who have received the vaccine dose are included in the WHO list internationally.

Expansion

Kovacin, India’s first indigenous vaccine to prevent the corona epidemic, is being approved internationally today. The decision could be taken at today’s World Health Organization (WHO) meeting.

The decision will be taken at the World Health Organization meeting today

WHO Chief Scientist Dr Soumya Swaminathan said last week that the meeting on October 26 would decide on the inclusion of Kovacin Vaccine of India Biotech in the world-class emergency use list.

The WHO said Bharat Biotech had provided all the documents related to Kovacsin, the review of which was almost complete. At Tuesday’s meeting, the committee’s experts will not only express their views, but also consider the vaccine’s effectiveness, safety and antibody level, based on which Kovacsin can be added to the list. Emergency use.

Covaxin is not yet internationally approved, making Covaxin supplements not eligible for overseas travel. In most countries, only people who have received a dose of the vaccine listed internationally are included.

.

[ad_2]

Source link

Leave a Comment